1 year return (CAGR)
-99.99%
Talaris Therapeutics Inc Exchange (NASDAQ, USD)
TALS
-
-27.40 (-99.99%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
128.43K
Price/Sales
-
Ent value
-58.77M
Price/Book
0.00
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 0.00 |
| Daily high | 0.00 |
| Daily low | 0.00 |
| Daily Volume | 303K |
| 1y analyst estimate | 20.00 |
| Beta | 2.18 |
| EPS (TTM) | -13.50 |
| Dividend per share | - |
| Ex-div date | 20 Oct 2023 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| TALS | S&P500 | |
| Current price drop from All-time high | -100.00% | -10.73% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 19 Oct 2023 | 9 Mar 2009 |
| Avg drop from high | -62.89% | -10.69% |
| Avg time to new high | 124 days | 12 days |
| Max time to new high | 598 days | 1805 days |
News
No items found